Acne treatment options in the United States are expanding after the U.S. Food and Drug Administration approved Differin Epiduo Acne Gel for over the counter use. The newly approved product combines adapalene 0.1% and benzoyl peroxide 2.5% in a single daily acne treatment designed for people aged 12 years and older.
This latest approval marks an important shift in acne care because the treatment was previously available only with a prescription. Now, consumers will have easier access to a dermatologist trusted formula that targets multiple causes of acne at the same time.
Differin Epiduo Acne Gel is a topical acne medication developed by Galderma. The gel combines two proven acne fighting ingredients:
Together, these ingredients help clear clogged pores, reduce acne causing bacteria, and decrease inflammation. The treatment is designed to improve acne breakouts while also enhancing overall skin texture and appearance.
According to Galderma, the formula uses a specialized Simulgel base that evenly distributes the active ingredients and helps improve tolerability for users. The once daily application makes it easier for consumers to maintain a consistent skincare routine.
The FDA approval announced on May 22, 2026, allows Differin Epiduo Acne Gel to be sold over the counter across the United States. This is considered a major prescription to OTC switch within the dermatology industry.
For many acne sufferers, especially teenagers and young adults, this means easier access to a clinically tested acne treatment without needing a doctor’s prescription.
Galderma stated that the product will become available at major retailers including Walmart, Target, Ulta, and Amazon during summer 2026.
Acne affects millions of people globally and remains one of the most common skin conditions. While there are many acne products available in stores, not all offer prescription strength ingredients backed by long term clinical research.
Differin Epiduo stands out because:
Dermatology guidelines often recommend combining retinoids with benzoyl peroxide because they address acne through multiple mechanisms. The combination helps reduce both inflammatory and non inflammatory acne lesions.
Galderma highlighted several clinical studies supporting the FDA approval.
Research demonstrated that the adapalene and benzoyl peroxide combination performed better than adapalene alone, benzoyl peroxide alone, and placebo gel in reducing acne lesions.
Some key study findings included:
The company also noted that the product has been evaluated in more than ten studies involving over 3,200 patients worldwide.
Adapalene belongs to a class of medications known as retinoids. These ingredients work by promoting skin cell turnover and preventing pores from becoming clogged.
Unlike earlier retinoids, adapalene was developed to improve both stability and skin tolerability. This makes it a popular option for acne patients who may experience irritation with stronger retinoid products.
Adapalene is already widely recognized in acne care because Differin Gel became one of the first prescription retinoids to successfully transition to OTC status several years ago.
Benzoyl peroxide remains one of the most trusted over the counter acne ingredients available today. It works by killing acne causing bacteria and reducing inflammation on the skin.
Combining benzoyl peroxide with adapalene allows the treatment to tackle multiple acne triggers simultaneously. This dual action approach may help improve overall treatment outcomes compared to using a single ingredient alone.
Galderma executives and dermatologists described the FDA approval as an important milestone for acne treatment access.
Bill Andriopoulos, Ph.D., Head of Global Medical Affairs at Galderma, explained that the adapalene and benzoyl peroxide combination aligns with dermatology guidelines recommending multimodal acne treatment.
Board certified dermatologist Dr. Heather Woolery Lloyd also noted that easier access and a simple once daily routine may improve patient consistency and treatment success.
Consumers can expect to find Differin Epiduo OTC at major retailers during summer 2026. Online marketplaces and pharmacies are also expected to stock the product.
The launch expands the existing Differin product line, which already includes cleansers, moisturizers, and acne spot treatments.
Outside the United States, Epiduo remains a prescription only medication.
As with many acne treatments, users may experience mild skin irritation during early use. Common side effects associated with adapalene and benzoyl peroxide products can include:
Consumers should carefully follow product instructions and consider using sunscreen during treatment.
People with severe acne, allergies, or ongoing skin conditions should consult a healthcare professional before starting any new acne medication.
The FDA approval of Differin Epiduo Acne Gel reflects a growing trend toward making clinically proven dermatology treatments more accessible without prescriptions.
As consumer demand for effective skincare continues to rise, companies are increasingly investing in scientifically backed formulations that bridge the gap between prescription and over the counter treatment options.
For acne sufferers seeking a dermatologist trusted treatment with prescription strength ingredients, Differin Epiduo OTC may become one of the most significant new skincare launches of 2026.
This article is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional or dermatologist before starting any medication or skincare treatment. Product availability, safety information, and FDA guidance may change over time.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.